Aigner A - Search Results

1

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo.

Wach S, Brandl M, Borchardt H, Weigelt K, Lukat S, Nolte E, Al-Janabi O, Hart M, Grässer F, Giedl J, Jung R, Stöhr R, Hartmann A, Lieb V, Höbel S, Peters A, Stäubert C, Wullich B, Taubert H, Aigner A. Wach S, et al. Among authors: aigner a. Mol Ther Nucleic Acids. 2019 Jun 7;16:272-283. doi: 10.1016/j.omtn.2019.02.020. Epub 2019 Feb 27. Mol Ther Nucleic Acids. 2019. PMID: 30933831 Free PMC article.

2

A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.

Werth S, Urban-Klein B, Dai L, Höbel S, Grzelinski M, Bakowsky U, Czubayko F, Aigner A. Werth S, et al. Among authors: aigner a. J Control Release. 2006 May 15;112(2):257-70. doi: 10.1016/j.jconrel.2006.02.009. Epub 2006 Mar 6. J Control Release. 2006. PMID: 16574264

3

RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.

Grzelinski M, Urban-Klein B, Martens T, Lamszus K, Bakowsky U, Höbel S, Czubayko F, Aigner A. Grzelinski M, et al. Among authors: aigner a. Hum Gene Ther. 2006 Jul;17(7):751-66. doi: 10.1089/hum.2006.17.751. Hum Gene Ther. 2006. PMID: 16839274

4

Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.

Höbel S, Prinz R, Malek A, Urban-Klein B, Sitterberg J, Bakowsky U, Czubayko F, Aigner A. Höbel S, et al. Among authors: aigner a. Eur J Pharm Biopharm. 2008 Sep;70(1):29-41. doi: 10.1016/j.ejpb.2008.03.014. Epub 2008 Mar 30. Eur J Pharm Biopharm. 2008. PMID: 18499413

5

Nonviral delivery platform for therapeutic RNAi: pegylated siRNA/cationic liposome complexes for targeting of the proto-oncogene bcl-2.

Höbel S, Aigner A. Höbel S, et al. Among authors: aigner a. Future Oncol. 2009 Feb;5(1):13-7. doi: 10.2217/14796694.5.1.13. Future Oncol. 2009. PMID: 19243292 No abstract available.

6

Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.

Höbel S, Koburger I, John M, Czubayko F, Hadwiger P, Vornlocher HP, Aigner A. Höbel S, et al. Among authors: aigner a. J Gene Med. 2010 Mar;12(3):287-300. doi: 10.1002/jgm.1431. J Gene Med. 2010. PMID: 20052738

7

Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.

Höbel S, Aigner A. Höbel S, et al. Among authors: aigner a. Methods Mol Biol. 2010;623:283-97. doi: 10.1007/978-1-60761-588-0_18. Methods Mol Biol. 2010. PMID: 20217558

8

Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.

Schäfer J, Höbel S, Bakowsky U, Aigner A. Schäfer J, et al. Among authors: aigner a. Biomaterials. 2010 Sep;31(26):6892-900. doi: 10.1016/j.biomaterials.2010.05.043. Epub 2010 Jun 18. Biomaterials. 2010. PMID: 20561681

9

Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma.

Schulze D, Plohmann P, Höbel S, Aigner A. Schulze D, et al. Among authors: aigner a. Mol Cancer. 2011 Nov 23;10:144. doi: 10.1186/1476-4598-10-144. Mol Cancer. 2011. PMID: 22111880 Free PMC article.

10

Polyethylenimines for siRNA and miRNA delivery in vivo.

Höbel S, Aigner A. Höbel S, et al. Among authors: aigner a. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Sep-Oct;5(5):484-501. doi: 10.1002/wnan.1228. Epub 2013 May 29. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013. PMID: 23720168 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page